日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Durable disease control following treatment with ALMB-0168, a novel Cx43 hemichannel agonist monoclonal antibody, in femoral osteosarcoma with lung metastases after chemotherapy failure: a case report

ALMB-0168(一种新型Cx43半通道激动剂单克隆抗体)治疗后,化疗失败的股骨骨肉瘤肺转移患者病情得到持久控制:病例报告

Xie, Xianbiao; Bian, Yiying; Yang, Xiugao; Zhang, Yanfeng; Yin, Junqiang; Shen, Jingnan

The Application of Orthopedic Surgical Robot-Assisted Technology in Various Clinical Scenarios Involving Bone Tumors

骨科手术机器人辅助技术在涉及骨肿瘤的各种临床场景中的应用

Yin, Hanxiao; Fu, Yiwei; Yikemu, Xirenijiang; Liu, Weihai; Zou, Changye; Xie, Xianbiao; Zhao, Zhiqiang; Sheng, Puyi; Shen, Jingnan; Yin, Junqiang

Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis.

曲克芦丁通过 CD155/SRC/β-catenin 信号轴抑制骨肉瘤的干性

Chen Junkai, Li Hongbo, Jin Qinglin, Li Xiaoguang, Zhang Yiwen, Shen Jingnan, Huang Gang, Yin Junqiang, Zou Changye, Li Xinyu, He Xin, Xie Xianbiao, Lin Tiao

Long-term oncological and functional outcomes in patients with bone sarcomas in the proximal femur undergoing unplanned surgery: A single-center retrospective cohort study

近端股骨骨肉瘤患者接受非计划手术后的长期肿瘤学和功能预后:一项单中心回顾性队列研究

Zhong, Guodong; Lin, Tiao; Wang, Yongqian; Yao, Hao; Aimaiti, Aierxiding; Xie, Xianbiao; Zou, Changye; Yin, Junqiang; Shen, Jingnan; Huang, Gang; Zhao, Zhiqiang

Treatment of benign lesions of the proximal femur in young pediatric patients using adult 3.5 mm proximal humerus locking plates

使用成人3.5毫米近端肱骨锁定钢板治疗儿童近端股骨良性病变

Zhao, Zhiqiang; Liu, Xin; Xie, Xianbiao; Zou, Changye; Yin, Junqiang; Li, Haomiao; Shen, Jingnan

A Phase 3 Study of the Efficacy and Safety of Pexidartinib in East Asian Patients with Tenosynovial Giant Cell Tumor

一项评估佩西达替尼治疗东亚腱鞘巨细胞瘤患者疗效和安全性的3期研究

Xu, Hairong; Wu, Po-Kuei; Ye, Zhaoming; Fan, Zhengfu; Li, Tao; Chen, Tom Wei-Wu; Shen, Jingnan; Yan, Wangjun; Achiwa, Issei; Yoh, Kazukoh; Kikumori, Kunika; Hiruma, Yoshiharu; Greenberg, Jonathan; Niu, Xiaohui

Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study

JMT103治疗不可切除或手术难度大的骨巨细胞瘤患者的疗效和安全性:一项多中心Ib/II期研究

Xu, Hairong; Zhou, Yong; Liang, Li; Shen, Jingnan; Yan, Wangjun; Wang, Jin; Li, Jianmin; Zhang, Xiaojing; Huang, Gang; Bi, Wenzhi; Guo, Zheng; Xiao, Yanbin; Lin, Jianhua; Yao, Weitao; Tong, Zhichao; Zhou, Wenxian; Zhang, Guochuan; Ye, Zhaoming; Wang, Dong; Yang, Jilong; Fan, Zhengfu; Liu, Caigang; Qu, Guofan; Zhang, Qing; Wei, Feng; Liu, Weifeng; Tu, Chongqi; Li, Hong; Yuan, Jing; Niu, Xiaohui

Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma

肿瘤指导下的ctDNA深度测序可检测微小残留病灶并预测骨肉瘤复发

Fu, Yiwei; Xu, Yu; Liu, Weihai; Zhang, Jiajun; Wang, Fen; Jian, Qijie; Huang, Gang; Zou, Changye; Xie, Xianbiao; Kim, Albert H; Mathios, Dimitrios; Pang, Fei; Li, Feng; Wang, Kai; Shen, Jingnan; Yin, Junqiang

Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma

超增强子衍生特征对骨肉瘤患者生存和肺转移的预后和预测价值

Huang, Guanyu; Zhang, Xuelin; Xu, Yu; Chen, Shuo; Cao, Qinghua; Liu, Weihai; Fu, Yiwei; Jia, Qiang; Shen, Jingnan; Yin, Junqiang; Zhang, Jiajun

A diagnostic signature developed based on the necroptosis-related genes and its association with immune infiltration in osteosarcoma

基于坏死性凋亡相关基因开发的诊断特征及其与骨肉瘤免疫浸润的关联

Bian, Yiying; Shi, Jixiang; Chen, Ziyun; Fang, Ji; Chen, Weidong; Zou, Yutong; Yao, Hao; Tu, Jian; Liao, Yan; Xie, Xianbiao; Shen, Jingnan